The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 3, 2009, Pages 145-149

  Jacobsen, Iben Brock ^a   Henriksen, Jan Erik ^a   Beck Nielsen, Henning ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; LIPID; METFORMIN; NEUTRAL INSULIN; PLACEBO;

ADULT; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPID BLOOD LEVEL; MALE; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; MEDICATION ADHERENCE; METFORMIN; MIDDLE AGED; OVERWEIGHT;

EID: 68949198356     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00380.x     Document Type: Article

References (27)

1. De Block CE, De Leeuw IH, Van Gaal LF. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care 2005 28 : 1649 55.
2. Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2002 87 : 1036 40.
3. Nathan DM, Cleary PA, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005 353 : 2643 53.
4. DCCT. The Effect Of Intensive Treatment Of Diabetes On The Development And Progression Of Long-term Complications In Insulin Dependent Diabetes Mellitus. N Engl J Med 1993 329 : 977 86.
5. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999 22 : 99 111.
6. Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 2007 30 : 2107 12.
7. Kenneth Cusi. Metformin: a review of its metabolic effects. Ralph A.DeFronzo, editor. Diabetes Reviews 2001 6 : 89 131.
8. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med 2002 137 : 25 33.
9. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 : 854 65.
10. Gin H, Messerchmitt C, Brottier E, Aubertin J. Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients. Metabolism 1985 34 : 923 5.
11. Janssen M, Rillaerts E, De L, I. Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). Biomed Pharmacother 1991 45 : 363 7.
12. Leblanc H, Marre M, Billault B, Passa P. [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics]. Diabete Metab 1987 13 : 613 7.
13. Pagano G, Tagliaferro V, Carta Q, Caselle MT, Bozzo C, Vitelli F et al. Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes. Diabetologia 1983 24 : 351 4.
14. Meyer L, Bohme P, Delbachian I, Lehert P, Cugnardey N, Drouin P et al. The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients. Diabetes Care 2002 25 : 2153 8.
15. Moon RJ, Bascombe LA, Holt RI. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being. Diabetes Obes Metab 2007 9 : 143 5.
16. Bailey CJ. Biguanides and NIDDM. Diabetes Care 1992 15 : 755 72.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
18. Sarnblad S, Kroon M, Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol 2003 149 : 323 9.
19. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 2003 26 : 138 43.
20. Khan AS, McLoughney CR, Ahmed AB. The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes. Diabet Med 2006 23 : 1079 84.
21. Daniel JR, Hagmeyer KO. Metformin and insulin: is there a role for combination therapy? Ann Pharmacother 1997 31 : 474 80.
22. Gin H, Freyburger G, Boisseau M, Aubertin J. Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics. Diabetes Res Clin Pract 1989 6 : 61 7.
23. Khan AS, McLoughney CR, Ahmed AB. The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes. Diabet Med 2006 23 : 1079 84.
24. Moon RJ, Bascombe LA, Holt RI. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being. Diabetes Obes Metab 2007 9 : 143 5.
25. Gomez R, Mokhashi MH, Rao J, Vargas A, Compton T, McCarter R et al. Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: a pilot study. J Pediatr Endocrinol Metab 2002 15 : 1147 51.
26. Lacigova S, Rusavy Z, Jankovec Z, Kyselova P. [Metformin in the treatment of type 1 diabetics - a placebo controlled study]. Cas Lek Cesk 2001 140 : 302 6.
27. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000 49 : 626 32.